News & Updates

Expectant mothers with high blood pressure (BP) levels before pregnancy are at increased risk of adverse pregnancy outcomes, as reported in a study.

In patients who have had a first attack of pericarditis with evidence of myocardial involvement, treatment with colchicine is safe and helps reduce the risk of recurrence, according to a study.

Being fat contributes to the development of cardiopulmonary (CP) multimorbidity (MM), reports a study. As a result, adiposity may be targeted by future interventions to help prevent MM.

Individuals who received a diagnosis of type 2 diabetes (T2D) at a young age appear to have a disproportionately increased risk of hospitalization for heart failure (HF), according to a study.

In the treatment of older patients with nonvalvular atrial fibrillation (AF) who are considered ineligible for oral anticoagulants at the recommended therapeutic strength or the approved doses, the use of low-dose edoxaban helps reduce the risk of stroke or systemic embolism regardless of body weight, although this benefit comes with a slightly higher major bleeding events, according to the subgroup analysis of the phase III ELDERCARE‐AF trial.

For patients who have undergone coronary artery bypass graft, initiating treatment with sacubitril/valsartan early is safe and appears to improve outcomes, as shown in an open-label study.

An international team of experts has identified 13 promising biomarkers to predict cardiovascular disease (CVD) risk in patients with type 2 diabetes mellitus (T2DM), of which N-terminal pro-brain natriuretic peptide (NT-proBNP) has shown the highest predictive utility with highest strength of evidence.

An elevated systolic blood pressure (BP) variability (BPV) in healthy older adults may lead to a higher risk of frailty regardless of their mean BP, suggests a study.